Reported Reactions

Devices › Device types

FDA product code MTA · class 3 · Unknown

Lens, intraocular, phakic: medical device reports filed with FDA

22,089 reports carry this product code, 2005–2026; 11 brands with a page.

22,089
reports with this product code
0.1% of all MAUDE reports
821
reports, 12 months to August 2026
1,098 in the 12 months before
19.2%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code MTA is FDA's classification for "Lens, intraocular, phakic" (unknown panel), a class 3 device. 22,089 medical device reports carry this product code, 0.1% of the MAUDE database, from December 2005 to August 2026.

821 reports arrived in the 12 months to August 2026, down 25% from 1,098 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (80.4%), malfunction (19.2%) and other (0.3%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Implantable Collamer Lens Icl13,396410%19.9%
Icl Implantable Collamer Lens4,47700%9.6%
Visian ICL (Implantable Collamer Lens)2,314100%24.9%
Implantable Collamer Lens59910.1%42.4%
EVO/EVO+VISIAN Implantable Collamer Lens4199780%0.1%
EVO/EVO+ VISIAN Implantable Collamer Lens2856720%0%
EVO/EVO+ VISIAN Implantable Collamer Lens (ICL)1654050%0%
EVO/EVO + VISIAN Implantable Collamer Lens (ICL)973170%0%
Silicone Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula600%73.6%
Collamer Ultraviolet-Absorbing Posterior Chamber Single Piece Foldable Intraocul200%64.3%
Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula200%65.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Staar Surgical22,00999.6%

Reports by month, five years

0114228Sep 2021: 178Oct 2021: 142Nov 2021: 149Dec 2021: 1812022Jan 2022: 118Feb 2022: 119Mar 2022: 153Apr 2022: 169May 2022: 154Jun 2022: 159Jul 2022: 182Aug 2022: 174Sep 2022: 138Oct 2022: 174Nov 2022: 218Dec 2022: 1592023Jan 2023: 121Feb 2023: 121Mar 2023: 180Apr 2023: 162May 2023: 182Jun 2023: 183Jul 2023: 209Aug 2023: 182Sep 2023: 184Oct 2023: 171Nov 2023: 198Dec 2023: 1832024Jan 2024: 165Feb 2024: 179Mar 2024: 179Apr 2024: 203May 2024: 182Jun 2024: 146Jul 2024: 176Aug 2024: 228Sep 2024: 199Oct 2024: 164Nov 2024: 157Dec 2024: 1702025Jan 2025: 70Feb 2025: 50Mar 2025: 56Apr 2025: 47May 2025: 37Jun 2025: 42Jul 2025: 57Aug 2025: 49Sep 2025: 53Oct 2025: 67Nov 2025: 51Dec 2025: 802026Jan 2026: 42Feb 2026: 68Mar 2026: 59Apr 2026: 69May 2026: 73Jun 2026: 79Jul 2026: 89Aug 2026: 91

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%2
Injury80.4%17,759
Malfunction19.2%4,251
Other0.3%70
Not given0%7

Who filed

Manufacturer report99.9%22,056
Voluntary report0.1%33
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Inadequacy of device shape and/or size10,64748.2%
Off-label use2,57211.6%
Device operates differently than expectedthe device behaved unexpectedly1,1845.4%
Explanted1,0694.8%
Misfocusing9904.5%
Lens, vaulting9444.3%
Device dislodged or dislocated4702.1%
Unintended movement4412%
Insufficient device problem information3931.8%
Optical problem3431.6%
Torn material3311.5%
Device remains implanted2461.1%
Other (for use when an appropriate device code cannot be identified)2141%
Patient-device incompatibilitythe device did not suit the patient1770.8%
Lens (iol), torn, split, cracked1120.5%
Breakthe device broke880.4%
Malposition of device770.3%
Improper or incorrect procedure or method750.3%
Positioning failure510.2%
Tears, rips, holes in device, device material470.2%

Questions about lens, intraocular, phakic reports

What is product code MTA?

FDA's classification code for "Lens, intraocular, phakic", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

22,089 reports through August 2026, 821 of them in the latest 12 months.

Which brands appear most often?

Implantable Collamer Lens Icl (13,396), Icl Implantable Collamer Lens (4,477), Visian ICL (Implantable Collamer Lens) (2,314), Implantable Collamer Lens (599) and EVO/EVO+VISIAN Implantable Collamer Lens (419). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.